|
Ac-MDKVLNRE
|
|
|
|
AMPs WR
|
|
|
|
Apidaecin IB
|
|
|
|
Aurein 1.1
|
|
|
|
B8R (20-27)
|
|
|
|
Bactenecin 2A
|
|
|
|
Biotinyl-KR-12 (human)
|
|
|
|
CD36 Peptide P(139-155)
|
|
|
|
CD36 Peptide P(93-110)
|
|
|
|
CEF1, Influenza Matrix Protein M1 (58-66)
|
|
|
|
CEF10, Epstein-Barr Virus LMP2 (426-434)
|
|
|
|
CEF11, Epstein-Barr Virus BMLF1 (280-288)
|
|
|
|
CEF12, Epstein-Barr Virus latent NA3B (399-408), AVF
|
|
|
|
CEF14, EBV Rta Protein (28-37)
|
|
|
|
CEF15, Epstein-Barr Virus Lytic Cycle Protein BZLF-1(190-197)
|
|
|
|
CEF16, Epstein-Barr Virus latent NA-3A (337-347)
|
|
|
|
CEF17, Epstein-Barr Virus latent NA-3A (158-166)
|
|
|
|
CEF18, Epstein-Barr Virus latent NA-3C (258-266)
|
|
|
|
CEF19, Epstein-Barr Virus latent NA-3A (458-466)
|
|
|
|
CEF2, Influenza Virus PA (46-54)
|
|
|
|
CEF21, Cytomegalovirus, CMV pp65 (417-426)
|
|
|
|
CEF22, Cytomegalovirus, CMV pp65 (378-389)
|
|
|
|
CEF23, Cytomegalovirus, CMV pp65 (123-131)
|
|
|
|
Indolicidin
|
|
|
|
Influenza A NP (366-374) Strain A/NT/60/68
|
|
|
|
Influenza A NP(366-374) Strain A/PR/8/35
|
|
|
|
Influenza HA (110-119)
|
|
|
|
Influenza HA (110-120)
|
|
|
|
Influenza HA (126-138)
|
|
|
|
Influenza HA (204-212)
|
|
|
|
Influenza HA (307-319)
|
|
|
|
CEF25, Influenza Virus NP (44-52)
|
|
|
|
CEF26, Influenza Virus NP (265-274)
|
|
|
|
CEF27, Epstein-Barr Virus BRLF-1 lytic (148-156)
|
|
|
|
CEF28, Epstein-Barr Virus latent NA-3A (603-611)
|
|
|
|
CEF29, Epstein-Barr Virus latent NA-3B (416-424)
|
|
|
|
CEF3
|
|
|
|
CEF30, Epstein-Barr Virus BRLF1 (134-142)
|
|
|
|
CEF31, Epstein-Barr Virus latent NA-3A (379-387)
|
|
|
|
CEF32, Epstein-Barr Virus latent NA-3C (281-290)
|
|
|
|
CEF33, Cytomegalovirus, HCMV pp65
|
|
|
|
CEF4
|
|
|
|
CEF5, Influenza Virus NP (91-99)
|
|
|
|
CEF6
|
|
|
|
CEF7, Influenza Virus NP (380-388)
|
|
|
|
|
CEF8,流感病毒NP 383-391
|
|
|
CEF9, Influenza Virus M1 128-135
|
|
|
|
CFP10 (71-85)
|
|
|
|
Chemerin-9 (149-157)
|
|
|
|
CHRG01
|
|
|
|
CMV pp65 peptide
|
|
|
|
Competence-Stimulating Peptide-2
|
|
|
|
CSP1
|
|
|
|
Drosocin
|
|
|
|
Flagelin 22
|
|
|
|
Glycoprotein (276-286)
|
|
|
|
GP(33-41)
|
|
|
|
HBV Core (107-115)
|
|
|
|
Influenza HA (518-526)
|
|
|
|
HCV, NS4A-Like Peptide
|
|
|
|
Histatin-8 [Hemagglutination-Inhibiting Peptide (HIP)
|
|
|
|
HIV p17 Gag (77-85)
|
|
|
|
HPV E7 protein (49-57)
|
|
|
|
HSV-1-amide UL 26 Open Reading Frame (242-255)
|
|
|
|
HSV-gB2 (498-505)
|
|
|
|
Human CMV pp65 (495-503)
|
|
|
|
Human Platelet Factor IV 18, C18G
|
|
|
|
CEF24, Influenza Virus PB1 Peptide (591-599)
|
|
|
|
Influenza HA (91-108)
|
|
|
|
Influenza Matrix Protein (61-72)
|
|
|
|
Influenza Virus A/Aichi/2/68 Haemagglutinin HA1 (195-209), X-31
|
|
|
|
Influenza Virus Nucleoprotein (311-325)
|
|
|
|
Innate Defense Regulator-1
|
|
|
|
IV9 (476-484), HIV-1 RT Epitope
|
|
|
|
KK4A
|
|
|
|
Lactoferricin
|
|
|
|
Lauryl-LF 11
|
|
|
|
LCMV GP (61-80)
|
|
|
|
LCMV gp33-41
|
|
|
|
LCMV-NP205
|
|
|
|
LF11 TFA
|
|
|
|
LL(17-29)
|
|
|
|
LL-37 (18-29)
|
|
|
|
LL-37 GKE
|
|
|
|
LL-37 KRI
|
|
|
|
NS2(114-121), Influenza
|
|
|
|
NS4A-NS4B Hepatitis Virus C
|
|
|
|
OV-1, sheep
|
|
|
|
PA (224-233), Influenza
|
|
|
|
Prepro VIP (111-122)
|
|
|
|
Prepro VIP (156-170)
|
|
|
|
Pyrrhocoricin
|
|
|
|
RIP (free acid)
|
|
|
|
SEB Domain (144-153)
|
|
|
|
LL-37 LLG
|
|
|
|
LL-37 SKE
|
|
|
|
LLO (91-99)
|
|
|
|
Lysozyme C (46-61) (chicken)
|
|
|
|
MMK-1
|
|
|
|
Mycobacterium tuberculosis Protein Ag85A
|
|
|